Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Anchorage. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Anchorage location
Access ovarian cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
Check if you qualify for this ovarian cancer clinical trial in Anchorage, AK
No-Cost Study Care
Local to Anchorage
Convenient for AK residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor and may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the format
Sponsor: NRG Oncology
Yes, this clinical trial (NCT06580314) has an active research site in Anchorage, AK that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for ovarian cancer treatment options in Anchorage, AK, this clinical trial (NCT06580314) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Anchorage research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all ovarian cancer clinical trials near you to find additional studies recruiting in your area.
See all ovarian cancer clinical trials recruiting in Anchorage — not just this study.
Browse Ovarian Cancer Trials in Anchorage →